Raycaster/ Eval

Havenor Therapeutics · Its newest medicine, Avericin, is finished and waiting for a health authority to approve it.

Task 10 · QC Stability Scientist

Decide which stability-testing operations can proceed

Review the package as the lab’s quality reviewer: decide what can proceed, what is held, and what evidence lifts each hold.

GPT-6.1 Sol caught 14 of 15 traps. See which →

3What just happened?

The lab needs to know which shelf-life tests can go ahead and which must wait.

The 24-month test campaign and the answers to the regulator’s questions are bundled in one working package. The lab can’t move until Quality says what may proceed, what is on hold, and what would lift each hold.

Workspace cutoff date: 27 September 2026.

4Who has to do what?

Review the package as the lab’s quality reviewer: decide what can proceed, what is held, and what evidence lifts each hold.

The seat
Viktor Takacs, QC Stability Scientist
What a good answer looks like
It gives an operation-by-operation go/hold decision, catches every expired or lapsing item, states the shelf-life trend plainly, and keeps one consistent timeline.
What must be handed in
STB-AVI401-002_24M_campaign_decision_and_response.xlsx
The assignment as the model received it
Viktor — Tomas has consolidated the STB-AVI401-002 24-month campaign and March authority-response evidence into one working decision package. Quality needs the QC operating position now: the laboratory must know which operations can proceed, what remains held, and what evidence will permit each hold to lift. Bring Tomas’s package through QC technical review in _Working/Tomas Li/STB-AVI401-002_24M_campaign_decision_and_response.xlsx. Preserve his baseline entries. Complete or correct the QC fields, calculations, cell comments, action ledger, and final disposition so accountable functions can execute without interpreting an ambiguous shared owner or gate. Use the information available today; distinguish conclusions QC can make now from evidence that does not yet exist, and state the next attributable review trigger for each conditional decision. Keep the review in that working copy. Do not alter source records or update LIMS, RIM, DMS, QMS, or any other governed system.

5Which files decide it?

The campaign workbook, equipment, calibration and reference-sample records, the shelf-life data, and the regulator’s questions.

The model also has the rest of the company’s shared drive, its chat and its record systems. Finding the right files is part of the job. Flip through the key ones below.

Company documents

Some of the documents available to the model.

Laboratory stability · workbook

The next results do not exist yet

The company date is 27 September 2026. The pull schedule distinguishes completed laboratory work from the next planned measurements.

An agent can prepare the update now, but cannot present the scheduled 24-month results as already reported.

STB-AVI401-002XLSX
Cells of the real STB-AVI401-002 study-status workbook, showing the next pull date.
Source excerpt · Study!A1:B8

6What did the model do?

What GPT-6.1 Sol did, step by step.

In short: Sol preserves the baseline, makes the holds executable, corrects the lot mapping and testing chain, applies the chamber, reference-standard, and calibration dates, and states the shelf-life trend plainly.

  1. Step 6. Inventories the campaign decision workbook and qualification records. Sol locates Tomas's consolidated campaign and authority-response workbook together with the laboratory qualification and calibration records.

    Tool call recorded in sessiontext(await tools.exec_command({cmd:"pwd && rg --files -g 'AGENTS.md' -g '*.xlsx'
  2. Step 23. Inspects the calibration and reference-standard certificates. Sol renders and checks the calibration and reference-standard records, applying the 5 November 2026 RS-AVR-014 expiry and the 29 November 2026 CCI-02 calibration limit.

    Tool call recorded in sessiontext(await tools.exec_command({cmd:"pdftoppm -r 120 -png -singlefile 'Laboratory
  3. Step 40. Completes the in-place QC review (14/15), missing only the combined timeline gate. Sol passes 14 of 15 checks—recomputing the OLS Impurity A bounds and setting operation-by-operation holds—missing only a single unified timeline linking the 12 November / 1 December test completions to the 6 November authority reply and 17 December commitment.

    Tool call recorded in sessiontext(await tools.exec_command({cmd:"python3 - <<'PY'\nfrom pathlib import Path\n

    Bears on: One timeline that adds up

Replay every step of the run →

Inside the run

model sessionTask 10 · step 6
A
Model

Inventories the campaign decision workbook and qualification records

Model draft
text(await tools.exec_command({cmd:"pwd && rg --files -g 'AGENTS.md' -g '*.xlsx'
A

Sol locates Tomas's consolidated campaign and authority-response workbook together with the laboratory qualification and calibration records.

1 / 3

7Which traps did it catch?

It caught 14 of 15.

Specialists wrote these checks from the records in the workspace. Each is a weak spot a reviewer or inspector would find. A check passes only when the submitted file provides the required evidence.

Missed

  1. One timeline that adds up R10

    Impurity tests run to 12 November and leak tests to 1 December, so the full dataset comes after the 6 November response, which must rely on existing evidence and name the gaps.

    If missed, the regulator is promised a complete dataset that can’t exist yet.

Caught

  1. Sign and date the review honestly R01

    The review is recorded under the reviewer’s name as of today (27 Sep 2026), without back- or forward-dating and without claiming to have changed official systems.

    If missed, nobody can tell who decided what, and when.

  2. Every fix needs an owner and a deadline R02

    Each problem sent back must name one responsible person, a due date, what it blocks, what evidence closes it, and exactly where that evidence lives.

    If missed, problems get flagged but never closed.

  3. Fix the batch-to-bag-size mix-up R03

    Two test batches are 100 mL bags and one is a 250 mL bag. The workbook wrongly lists a 250 mL and a 500 mL batch; there is no 500 mL batch.

    If missed, the wrong bags get tested and the worst case is never checked.

  4. List the complete testing chain R04

    Every test in the specification needs its storage chamber, method, instrument and reference sample listed, and nothing unrelated.

    If missed, a test can start with an unqualified piece of the chain.

  5. The storage chamber’s approval runs out R05

    The chamber holding the samples is calibrated until July 2027, but its separate qualification ends 17 October 2026, the day before the samples are due.

    If missed, the samples sit in an unqualified chamber and their results can be challenged.

  6. A reference sample expires mid-campaign R06

    The reference sample expires 5 November 2026. It can support the strength tests planned for 1–4 November, not the impurity tests planned for 8–12 November.

    If missed, the impurity results are measured against an expired reference.

  7. An instrument’s calibration ends before use R07

    The leak-test instrument was calibrated 29 November 2025 for 12 months, so it is out of calibration for its planned use on 30 November–1 December 2026.

    If missed, the leak-test results are invalid.

  8. Show the math so anyone can redo it R08

    The shelf-life calculation uses each batch’s actual results and gives projections and error figures others can reproduce.

    If missed, nobody can check the shelf-life conclusion.

  9. State the trend conclusion plainly R09

    Every batch’s upper estimate crosses the limit before 36 months; the worst at about 26.8 months. Today’s data don’t support 36 months.

    If missed, the key finding is buried and the shelf life stays overstated.

  10. Answer all seven regulator questions R11

    The regulator asked seven numbered questions, including a small one about the filing’s page layout. Each needs an owner, the evidence required, and a route back to the regulator.

    If missed, an unanswered question delays approval.

  11. Answer about the current wrapper R12

    The oxygen answer cites the approved wrapper and admits nobody has measured oxygen inside the bags; the proposed new film is out of scope.

    If missed, the regulator gets evidence about a wrapper that isn’t in use.

  12. “Within the limit” doesn’t settle it R13

    An accelerated-test result of 0.46% is under the 0.50% limit, but conflicting records mean someone must still formally decide whether it counts as a “significant change”.

    If missed, a formal regulatory question is waved away.

  13. Did the lab error hit other tests? R14

    A past test run was thrown out because of a mixing mistake. The record needs the cause, the replacement result, and a check of whether the same mistake affected other runs.

    If missed, other results made with the same mistake stay on file.

  14. Don’t claim more than the evidence shows R15

    The filter and IV-set answers must stay within the tested limits and name what’s missing, such as a hold longer than 8 hours being untested.

    If missed, the regulator is told something is covered when it isn’t.

Every model on the same job

One published attempt each, on the same assignment and checklist, so treat small gaps as noise.

Scores on this page are from the published biopharma-bench@v0.2 package (130 checks across these ten tasks).

Workbook changes

STB-AVI401-002_24M_campaign_decision_and_response.xlsx

Selected cells before and after the model’s edits. Longer entries are shortened here.

1225cells changed across the submitted workbook
QC Navigation32 changed cells
CellBaselineSubmitted entry / excerpt
A1BlankQC technical review — 7 November 2026
B1BlankWorking copy only; Tomas baseline preserved
Control10 changed cells
CellBaselineSubmitted entry / excerpt
C2BlankTomas Li baseline preserved; QC technical review completed in this working copy.
C3BlankQC review date: 2026-11-07. Preparation date 2026-09-25 retained in baseline.
Operation Gates80 changed cells
CellBaselineSubmitted entry / excerpt
E2BlankHOLD — storage / sample gate
F2BlankCHM-25-03 requalification 2023-10-17+36 m=2026-10-17, before 18 Oct pull. Calibration 2026-07-17 is separate. No executed 24 m pull evidenced as of 7 Nov.
Qualified Chain96 changed cells
CellBaselineSubmitted entry / excerpt
F2BlankGO technically; sample gate remains
G2BlankCorrect instrument=N/A; MTH-VIS-002 direct visual examination, method revalidated 29 Jan 2025 to 29 Jan 2030. UV-02 isout of scope; use method viewing station controls.
Impurity A Analysis24 changed cells
CellBaselineSubmitted entry / excerpt
I2Blank='QC Trend Calculations'!K10
J2Blank='QC Trend Calculations'!L10
Authority Response67 changed cells
CellBaselineSubmitted entry / excerpt
D2BlankAdministrative correction; technical QC N/A
E2BlankPoint 1 requests corrected P.7 bookmarks/pages only; no new technical content. A named publishing owner and reviewed leaf are still required.
Action Ledger277 changed cells
CellBaselineSubmitted entry / excerpt
B2BlankOperation Gates E 2; Qualified Chain F 12
C2BlankRestore CHM-25-03 qualified state; 36 m anniversary is 2026-10-17, before pull. Calibration does not reset it.

Talk to usRequest the full Biopharma Bench V0.2, company environments and run receipts: team@raycaster.ai